Spiriva HandiHaler (tiotropium bromide inhalation powder), Do Not Swallow Spiriva Capsules, For U...

FDA Drug Recall #D-1230-2014 — Class III — March 27, 2014

Recall Summary

Recall Number D-1230-2014
Classification Class III — Low risk
Date Initiated March 27, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Boehringer Ingelheim Roxane Inc
Location Columbus, OH
Product Type Drugs
Quantity 1,276,710 Blister Cards

Product Description

Spiriva HandiHaler (tiotropium bromide inhalation powder), Do Not Swallow Spiriva Capsules, For Use With HandiHaler Only, 18 mcg (as tiotropium) per capsule, Rx Only, a) NDC 0597-0075-75, 5 Spiriva capsules per blister card, b) NDC 0597-0075-41, 30 Spiriva capsules per blister card, Manufactured by: Boehringer Ingelheim (BI) Pharma, GmbH & Co. KG, Ingelheim, Germany, Marketed by: Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT 06877 USA and Pfizer Inc New York, NY 10017 USA, Made in Germany.

Reason for Recall

Defective Delivery System: Potential for dose delivery out of specification due to interation of the drug product powder with the lubricant on the interior of the capsule shell.

Distribution Pattern

Nationwide and Puerto Rico

Lot / Code Information

a) 5 count capsule blister card: 303012A, Exp Sep 2014; b) 30 count capsules blister card: 303012B, Exp Sep 2014, 303125A, 303253A, Exp Oct 2014, 303895A, 304282A, Exp Nov 2014, 304510A, Exp Dec 2014

Other Recalls from Boehringer Ingelheim Roxane Inc

Recall # Classification Product Date
D-0012-2016 Class III FUROSEMIDE Tablets USP, 40 mg, 1000-count bottl... Sep 25, 2015
D-0011-2016 Class III FUROSEMIDE Tablets USP, 20 mg, 1000-count bottl... Sep 25, 2015
D-1279-2015 Class II COMBIVENT RESPIMAT (ipratropium bromide and alb... Jul 24, 2015
D-1085-2015 Class II Acarbose Tablets 50 mg a)10 x 10 Unit Dose Tabl... Apr 2, 2015
D-1486-2014 Class III OXYCODONE HYDROCHLORIDE C II Oral Solution USP,... Jul 28, 2014

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.